Evidence map›Paper›PMID 41469919›Full record

ArticleJournal of experimental & clinical cancer research : CR2025

Neutrophil-macrophage crosstalk via NETs-IL-17/VEGF/S100A9 axis promotes hepatocellular carcinoma progression.

Rong Wu, Rui Wu, Xuehua Kong, Xuanyi Wang, Yaqian Duan, Shiyu Cao, Shan Yu, Yuqing Zhao, Shue Li, Jingying Zhou and 1 more

Abstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rong Wu *Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China.
Rui Wu *Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400000, China.
Xuehua Kong *Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China.
Xuanyi WangDepartment of Pathology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Yaqian DuanDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China.
Shiyu CaoDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China.
Shan YuDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China.
Yuqing ZhaoDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China.
Shue LiDepartment of Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Jingying ZhouSchool of Biomedical Sciences, The Chinese University of Hong Kong, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, Shatin, Hong Kong, 999077, China. zhoujy@cuhk.edu.hk.ORCID http://orcid.org/0000-0002-9740-6159
Liang DuanDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, No.74 linjiang Road, Yu Zhong District, Chongqing, 400010, China. duanliang@cqmu.edu.cn.ORCID http://orcid.org/0000-0002-3882-7527

Funding

Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) 2025ZDXM016Natural Science Foundation of Chongqing CSTB2023NSCQMSX0037Natural Science Foundation of Chongqing CSTB2024NSCQMSX0342Senior Medical Talents Program of Chongqing for Young and Middle-aged 2022-15the National Natural Science Foundation of China 82472354
6 · The paper itself

Abstract

backgroundTumor-associated neutrophils and macrophages are key components of the hepatocellular carcinoma (HCC) microenvironment. However, the interplay between them and its contribution to HCC progression remain unclear.

methodsBioinformatic analysis of TCGA datasets and clinical HCC samples was used to evaluate neutrophil extracellular trap (NETs) levels and macrophage polarization. Co-culture of neutrophils, macrophages, and HCC cells, along with molecular analysis and in vivo mouse models, were employed to dissect the mechanisms underlying NETs-mediated macrophage reprogramming and tumor progression.

resultsNETs were significantly elevated in HCC patients, particularly in advanced and metastatic stages, which were positively correlated with intrahepatic M2 macrophage infiltration and M2d subset-associated cytokines in blood. In vitro, NETs promoted M2d polarization in the presence of HCC cells via IL-17R/NF-κB signaling activated by IL-17 carried within NETs, which subsequently enhanced angiogenesis, migration, invasion, and epithelial-mesenchymal transition; these effects were partially reversed by IL-17R inhibition. In vivo, NETs-induced M2d polarization accelerated tumor growth, angiogenesis, and metastasis, whereas IL-17R blockade attenuated these pro-tumor effects. Moreover, M2d macrophages indirectly promoted NETs formation by upregulating HCC cell-derived S100A9 through VEGF-NF-κB signaling, establishing a positive feedback loop between neutrophils and macrophages. Furthermore, IL-17 carried by NETs (NETs-IL-17) demonstrated strong predictive value for extrahepatic metastasis in HCC, with an area under the ROC curve (AUC) of 0.89.

conclusionsA positive feedback loop between neutrophils and macrophages via the NETs-IL-17/VEGF/S100A9 axis accelerates HCC progression and metastasis. More importantly, NETs-IL-17 exhibited potential as an alternative biomarker for predicting extrahepatic metastasis in HCC.

Indexed as

Calgranulin BCarcinoma, HepatocellularExtracellular TrapsInterleukin-17Liver NeoplasmsMacrophagesNeutrophilsVascular Endothelial Growth Factor AAnimalsCell Line, TumorDisease ProgressionFemaleHumansMaleMiceSignal TransductionCalgranulin BInterleukin-17S100A9 protein, humanVascular Endothelial Growth Factor AVEGFA protein, humanHCCMacrophageNETsNeutrophilVEGF

Identifiers

PMID41469919
PMCPMC12853889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.